<DOC>
	<DOC>NCT01394380</DOC>
	<brief_summary>The study will enroll 68 overweight male and female subjects with a high (&gt; 2 3dl-can soda/day) consumption of sweetened beverage per day. After a run-in period of 4 weeks, subjects will be randomized to either a 12-week intervention arm in which sweetened beverages will be replaced by artificially sweetened, calorie-free beverages, or to a control arm. The following measurements will be performed at the end of the run-in period and at the end of the intervention period - intrahepatic fat concentration - visceral fat volume - changes in day-long metabolic profile from baseline(plasma glucose, insulin, and triglyceride concentrations) - changes in food intake and daily energy, carbohydrate and sugars intake from baseline</brief_summary>
	<brief_title>Reduction of Sweetened Beverages and Intrahepatic Fat</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>gender male or female body mass index (BMI) &gt; 27 kg/m2 consumption of &gt; 2 3dlcan regular soda/day low to moderate physical activity (&lt; 60 min walking/day; &lt; 3 exercise session/week diabetes mellitus liver, kidney or heart disease any current drug treatment contraindications to MR examination (pacemaker, foreign bodies,etc) pregnancy or planned pregnancy active weight gain or weight loss (weight change &gt; 4 kg in the past 12 months) consumption of drugs or illicit substances consumption of more than 10g alcohol/day vegetarians or subjects on special diets</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>sugar</keyword>
	<keyword>sweetened beverages</keyword>
	<keyword>hepatic steatosis</keyword>
	<keyword>visceral obesity</keyword>
	<keyword>metabolic syndrome</keyword>
</DOC>